LISINOPRIL-FORMULIERUNGEN

European patent · EP3368012 · Deleted

Register entry

Publication number
EP3368012
Application number
EP16860888
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Oct 28, 2016
Published
Sep 5, 2018
Granted
Aug 11, 2021
Deleted
Jun 1, 2022
Reason
Annual fee unpaid
IPC classes
A61K 9/00 (2006.01)
A61K 31/401 (2006.01)
A61K 38/55 (2006.01)
A61K 38/05 (2006.01)
A61K 47/02 (2006.01)
A61K 47/12 (2006.01)
A61K 47/26 (2006.01)
A61P 9/04 (2006.01)
A61P 9/12 (2006.01)
A61P 43/00 (2006.01)
Priority
US 201562249011 P 30.10.2015
US 201514934752 06.11.2015
PCT application
PCT/US2016/059348 28.10.2016
PCT publication
WO2017/075368 04.05.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 22, 2022

    Change

    Published in Swissreg on 22.06.2022

  2. Jun 1, 2022

    Deleted, fee unpaid

    Published in Swissreg on 01.06.2022

  3. Aug 11, 2021

    Granted

    Published in Swissreg on 11.08.2021

Parties

Inventor

MOSHER, Gerold L.

Kansas City, MS 64145, US

MILES, David W.

Kansas City, MS 64145, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.